KUALA LUMPUR (Oct 20): Bintai Kinden Corp Bhd has entered into a distribution agreement with Scientillence Sdn Bhd for the non-exclusive distribution of hemodialyzer in the private and commercial sector. 

In a statement Wednesday, the firm said its subsidiary Bintai Healthcare Sdn Bhd signed the agreement for a one-year period, which can be extended an additional five years subject to terms and conditions.

Bintai Kinden expects the agreement to contribute positively to its future earnings. 

The group said Scientillence is owned by former chief executive officer and chairman of Pantai Holdings Bhd Tan Sri Lim Tong Yong, and is the sole manufacturer of dialyzers in Malaysia as well as Southeast Asia. 

“The company (Scientillence) has obtained Quality Management System accreditation for its manufacturing business and various certifications for its products. It is also in the registration process for CE (Conformite European) and the first “Halal” certified manufacturer of dialyzer in the world,” it added.

Currently, Scientillence’s products are exported mainly to China, India, Pakistan, Bangladesh, Saudi Arabia, Turkey, Lebanon and most of the Southeast Asia countries. 

Bintai Kinden said that under the distribution agreement, Scientillence will be providing all necessary technical support and services in relation to the marketing and selling of the products.

The group’s deputy chief executive officer Azri Azerai said the appointment will further enhance Bintai Healthcare’s position as a distributor of medical devices and healthcare solutions in Malaysia. 

“With more distributorships coming in the pipeline, the group foresees even further upside potential for Bintai Healthcare. 

To add to this, we are also excited about a few more opportunities in the pipeline that we are working hard on and we hope to deliver more good news in the near future,” he added.  

At noon break, Bintai Kinden stood at 44 sen, up 2.33% and valuing the company at RM168.03 million.